Nobuo Shinohara

6PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCell physiologyJapanese languageMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 14, 2026
Stage- and Age-Specific Survival According to Histological Subtype in Renal Cell Carcinoma: A Nationwide Hospital-Based Cancer Registry Analysis in Japan.

|Aug 24, 2026
Short Pretransplant Dialysis Periods are Clinically Acceptable Without Compromising Kidney Transplant Outcomes: A Japanese Multicenter Study.

|Jan 04, 2026
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan.

Shuhei Yamada, Miho Sato, Takahiro Osawa

|Sep 24, 2025
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab.

Tokiyoshi Tanegashima, Masaki Shiota, Shusuke Akamatsu

|Jun 14, 2024
Cross-sectional study of therapy-related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan.

Go Kimura, Yasuhisa Fujii, Takahiro Osawa

|Jul 26, 2023
Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care).

Takahiro Osawa, Yasuhisa Fujii, Go Kimura

Pageof 1

Frequent Collaborators

2 joint publications

Takahiro Osawa

1 joint publications

Go Kimura

1 joint publications

Yasuhisa Fujii

1 joint publications

Tokiyoshi Tanegashima